Concepedia

Erkan Baloglu

EB

Statistics

Publications

58

Citations

4.5K

H-Index

36

Active since

1999

Affiliations

Karyopharm Therapeutics (United States)(Current)

Wayne State University

National University of Singapore

University of California, Los Angeles

National University Cancer Institute, Singapore

Erkan Baloglu is an author at Karyopharm Therapeutics (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyPharmacologyTumor BiologyDrug DiscoveryImmunologyRadiation OncologyCancer BiologyCell SignalingNatural Sciences

Publications per year

1999–2023

58

Publications

58

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

Mercedes Lobera, Kevin P. Madauss, Denise Teotico Pohlhaus et al. · Nature Chemical Biology · 2013 · 368 citations

Histone Modifications, Chromatin, Nonchelating Zinc-binding Group +9

The Taxane Diterpenoids

Erkan Baloglu, David G. I. Kingston · Journal of Natural Products · 1999 · 307 citations

Biology, Biosynthesis, Engineering +13

Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms

Sheng Xiao, Nir Yosef, Jianfei Yang et al. · Immunity · 2014 · 274 citations · Full text

Transcriptional Regulation, Signal Transduction, Signaling Pathway +10

Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma

Yan-Yi Jiang, De‐Chen Lin, Anand Mayakonda et al. · Gut · 2016 · 233 citations · Full text

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

Jimi Kim, Elizabeth A. McMillan, Hyun Seok Kim et al. · Nature · 2016 · 207 citations · Full text

Tumor Biology, Xpo1-dependent Nuclear Export, Oncology +10

1–5 of 58